col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


25 Results       Page 1

 [1] 
Dove Medical Press: Therapeutics and Clinical Risk Management
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―22 Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study Ahmed Khalil, Asmaa Mohamed, Manasik Hassan, Samar Magboul, Hossamaldein Ali, Ahmed Elmasoudi, et al. (+6)
2 [GO] 2023―Sep―18 Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis Heather Anderson, Vanessa Patterson, Garth Wright, Julia Rawlings, Gina Moore, Jim Leonard, Robert Page II
3 [GO] 2023―Jul―18 The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Maria Komariah, Shakira Amirah, Sidik Maulana, Muhammad Fahd Abdurrahman, Kusman Ibrahim, Hesti Platini, et al. (+4)
4 [GO] 2022―May―31 Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis Jean-Christophe Lagier, Matthieu Million, Sébastien Cortaredona, Léa Delorme, Philippe Colson, Pierre-Edouard Fournier, et al. (+3)
5 [GO] 2022―May―19 The Role of D-Dimers in the Initial Evaluation of COVID-19 [Response To Letter] Liliana Baroiu, Ana Cristina Lese, Ioana Anca Stefanopol, Alina Iancu, Caterina Dumitru, Alexandru Bogdan Ciubara, et al. (+6)
6 [GO] 2022―May―17 Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China Junyi Jiang, WeiJun Zhong, WeiHua Huang, Yongchao Gao, Yijing He, Xi Li, et al. (+5)
7 [GO] 2022―Apr―28 Letter to the Editor: The Role of D-Dimers in the Initial Evaluation of COVID-19 [Letter] Sachin Patel
8 [GO] 2022―Mar―31 The Role of D-Dimers in the Initial Evaluation of COVID-19 Liliana Baroiu, Ana Cristina Lese, Ioana Anca Stefanopol, Alina Iancu, Caterina Dumitru, Alexandru Bogdan Ciubara, et al. (+6)
9 [GO] 2021―Nov―15 Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study Toussaint Rouamba, Houreratou Barry, Espérance Ouédraogo, Marc Christian Tahita, Nobila Valentin Yaméogo, Armel Poda, et al. (+14)
10 [GO] 2021―Sep―20 Doxycycline in the Coronavirus Disease 2019 Therapy Karolina Dorobisz, Tadeusz Dorobisz, Dariusz Janczak, Tomasz Zatoński
11 [GO] 2021―Sep―13 The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: A Case-Control Study Rami A Al-Dwairi, Hamzeh Rwashdeh, Moneera Otoom
12 [GO] 2021―Aug―16 Clinical Characteristics and Factors Associated with Disease Progression of Mild to Moderate COVID-19 Patients in a Makeshift (Fangcang) Hospital: A Retrospective Cohort Study Jia Liu, Jun-Fei Zhang, Han-Ning Ma, Ke Feng, Zhong-Wei Chen, Li-Shan Yang, et al. (+2)
13 [GO] 2021―Jun―29 Therapeutic Agents Rounding Up the Immunopathology of COVID-19 Hong Peng Li, Xuan He, Liu Zhang, Chuan Xiang Li, Shi Qi Li, Qing Yun Li
14 [GO] 2021―May―31 Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease Changli Tu, Guojie Wang, Yayuan Geng, Na Guo, Ning Cui, Jing Liu
15 [GO] 2021―Apr―28 Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review Sultan AM Saghir, Naif A AlGabri, Mahmoud M Alagawany, Youssef A Attia, Salem R Alyileili, Shaaban S Elnesr, et al. (+13)
16 [GO] 2021―Jan―05 Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort Study Shengyu Zhou, Jiawei Xu, Wenqing Sun, Jintao Zhang, Fayan Zhang, Xuesong Zhao, et al. (+24)
17 [GO] 2020―Dec―07

Novel Deep Learning Technique Used in Management and Discharge of Hospitalized Patients with COVID-19 in China

Qingcheng Meng, Wentao Liu, Pengrui Gao, Jiaqi Zhang, Anlan Sun, Jia Ding, et al. (+2)
18 [GO] 2020―Nov―01

N-Acetylcysteine to Combat COVID-19: An Evidence Review

Zhongcheng Shi, Carlos A Puyo
19 [GO] 2020―Oct―28

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia - Case Reports

Chiara Scelfo, Matteo Fontana, Eleonora Casalini, Francesco Menzella, Roberto Piro, Alessandro Zerbini, et al. (+4)
20 [GO] 2020―Oct―19

The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications

Sayeeda Rahman, Keerti Singh, Sameer Dhingra, Jaykaran Charan, Paras Sharma, Salequl Islam, et al. (+4)
21 [GO] 2020―Oct―06

The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19)

Mojgan Sheikhpour
22 [GO] 2020―Aug―17

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

Sherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, et al. (+10)
23 [GO] 2020―Jul―21

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Sherif M Hamdy, Maged Abdel-Naseer, Hatem S. Shehata, Amr Hassan, Alaa Elmazny, Nevin M Shalaby, et al. (+9)
24 [GO] 2020―Jul―02

Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen

Mahtabalsadat Mirjalili, Mojtaba Shafiekhani, Afsaneh Vazin
25 [GO] 2020―Jun―29

Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review

Parisa Ghasemiyeh, Afshin Borhani-Haghighi, Iman Karimzadeh, Soliman Mohammadi-Samani, Afsaneh Vazin, Anahid Safari, Adnan I Qureshi
 [1] 

25 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec